Stay updated with breaking news from Progress Poster Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in...
/PRNewswire/ -- Eisai announced today the presentation of six abstracts across various gastrointestinal cancers during the 2022 American Society of Clinical...
AstraZeneca will present new data in liver, biliary tract and prostate cancers illustrating its ambition to revolutionise cancer care at the 2022
Press release content from Business Wire. The AP news staff was not involved in its creation. Lantheus Holdings Announces Presentations Featuring its PSMA-Targeted Pipeline Product Candidates at the 2021 ASCO GU Annual Meeting February 4, 2021 GMT NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Feb 4, 2021-- Lantheus Holdings, Inc. (NASDAQ: LNTH) (the “Company”), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products, announced ...
ó stata avanzado; presentaciones orales para destacar los resultados de los estudios de fase 3 ACIS, TITAN y SPARTAN SOLO PARA MEDIOS DE COMUNICACIÓN MÉDICOS Y COMERCIALES FARMACÉUTICOS DE LA REGIÓN DE EMEA NO SE PERMITE LA DISTRIBUCIÓN EN EL BENELUX NI EN EL REINO UNIDO Janssen Pharmaceutical Companies de Johnson & Johnson ha anunciado hoy que destacará la solidez de su cartera de tumores sólidos en el Simposio sobre Cánceres Genitourinarios de la Sociedad Americana de Oncología Clínica (American Society of Clinical Oncology Genitourinary, ASCO GU) con 12 presentaciones de datos,...